Sheng Ding is an experienced biopharmaceutical professional currently serving as a Director at Gilead Sciences since February 2019, following a progression from Senior Research Scientist I to Senior Research Scientist II within the same organization. Prior to Gilead, Sheng held the position of Principal Scientist at Pfizer, focusing on antibody engineering in Cancer Immunology Discovery from June 2016 to February 2019. Earlier roles include Senior Scientist at Amunix and a Research Associate at Stanford University, where a PhD was obtained with a focus on collagenous proteins for biomedical applications. Sheng holds a Master's in Biosciences from Northwestern University and a Bachelor's in Biotechnology from Tsinghua University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices